Anixa Biosciences, Inc. (FRA:CY71)

Anixa Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is November - October.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 1, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Market Capitalization	130	104	93	174	124	42
Market Cap Growth	32.19%	11.62%	-46.48%	40.55%	193.79%	-40.06%
Enterprise Value	116	84	68	141	91	34
Last Close Price	3.96	3.26	2.96	5.44	4.04	1.74
PS Ratio	-	-	467.53	-	279.02	-
PB Ratio	9.67	5.96	4.20	6.09	4.11	5.93
P/TBV Ratio	8.98	5.63	4.03	5.91	4.03	5.59
EV/Sales Ratio	-	-	342.38	-	206.32	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Asset Turnover	-	-	0.01	-	0.02	-
Quick Ratio	7.76	8.04	11.89	14.60	28.13	7.62
Current Ratio	8.45	8.55	12.50	14.83	28.35	7.88
Return on Equity (ROE)	-62.15%	-60.10%	-38.51%	-43.74%	-61.02%	-154.36%
Return on Assets (ROA)	-36.95%	-36.70%	-24.61%	-26.02%	-35.92%	-81.88%
Return on Capital (ROIC)	-41.00%	-40.52%	-26.48%	-27.34%	-37.88%	-98.19%
Return on Capital Employed (ROCE)	-76.90%	-72.40%	-46.90%	-48.90%	-37.50%	-124.80%
Earnings Yield	-7.46%	-11.15%	-9.99%	-7.92%	-9.07%	-20.44%
FCF Yield	-	-6.51%	-6.32%	-3.78%	-3.46%	-12.63%
Buyback Yield / Dilution	-2.02%	-2.96%	-1.99%	-6.28%	-28.57%	-12.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.